News & Opinion

Covering the life sciences inside and out

Most Recent

Gonococcal immune suppression

By | February 18, 2002

Patients infected with Neisseria gonorrhoea present with intense inflammation resulting in urethral or cervical pus discharge, but the specific immune response to the bacteria is weak and does not protect against subsequent gonococcal infections. In February 19 online Nature Immunology, Ian Boulton and Scott Gray-Owen from University of Toronto, Canada, show that N. gonorrhoea have a mechanism that can arrest the activation and proliferation of CD4+ T lymphocytes via the CEACAM1 adhesion molecul

0 Comments

Cash boost for research access

By | February 15, 2002

The campaign for freedom of access to scientific research has been given a $3 million boost.

0 Comments

Diagnosing cancer with artificial neural networks

By | February 15, 2002

Artificial neural networks can efficiently distinguish human subtypes of neoplastic colorectal lesions.

0 Comments

Viruses on the brain

By | February 15, 2002

Viral delivery of Cre recombinase can result in genetic engineering in the nervous system of adult mice.

0 Comments

Premature death

By | February 14, 2002

Although mice cloned by somatic-cell nuclear transfer appear relatively normal, the long-term consequences of cloning are now becoming apparent. In an Advanced Online Publication from Nature Genetics, Ogonuki et al. report that cloned mice die earlier than normal animals (Nat Gen 2002, DOI:10.1038/ng841).They followed 12 male mice cloned from immature Sertoli cells, together with genetically matched controls and mice generated by spermatid injection. The cloned mice grew normally, but they began

0 Comments

Suicide gene therapy for colon cancer

By | February 14, 2002

Injection of suicide gene modified tumor cells induces a systemic antitumor response in a rat model of metastatic colon carcinoma.

0 Comments

Building brand new kidneys

By | February 13, 2002

Advanced Cell Technology has sparked yet more controversy with its claim to have grown kidney-like organs.

0 Comments

Cloning from lymphocytes

By | February 13, 2002

Cloning animals from nuclei that are genetically marked by terminal differentiation remains inefficient, with most clones dying during gestation. In February 10 online Nature, Konrad Hochedlinger and Rudolf Jaenisch from Massachusetts Institute of Technology, Cambridge, USA, show that monoclonal mice can be generated by nuclear transfer from mature B and T donor cells. Hochedlinger & Jaenisch transferred nuclei from peripheral lymph node cells of mice into enucleate oocytes. From the resulti

0 Comments

Time control

By | February 13, 2002

The mammalian circadian clock is based on autonomous rhythmic expression of several clock genes in the pituitary gland, but how these signals are disseminated into the periphery remains unclear. In February 11 online Nature Neuroscience, Charlotte von Gall and colleagues from Johann Wolfgang Goethe-University, Frankfurt, Germany, show that rhythmic gene expression in the pituitary is linked with the release of the neurohormones melatonin and prolactin.von Gall et al. used rodent pituitary cells

0 Comments

Vasculature mapping

By | February 13, 2002

A few years ago Renata Pasqualini and Erkki Ruoslahti developed an in vivo selection method to identify peptides that target specific vascular beds following intravenous administration of random peptide phage-display libraries in mice. In the February issue of Nature Medicine, Pasqualini's group at the MD Anderson Cancer Center in Texas report the application of 'in vivo phage display' to characterize the human vasculature (Nat Med 2002, 8:121-127).They injected a large-scale, random peptide lib

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech